Skip to main content

Peer Review reports

From: Insights of different analytical approaches for estimation of budesonide as COVID-19 replication inhibitor in its novel combinations: green assessment with AGREE and GAPI approaches

Original Submission
19 Oct 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
1 Nov 2022 Reviewed Reviewer Report
10 Nov 2022 Reviewed Reviewer Report
12 Nov 2022 Reviewed Reviewer Report
5 Dec 2022 Author responded Author comments - Mohammed E. A. Hammouda
Resubmission - Version 3
5 Dec 2022 Submitted Manuscript version 3
8 Dec 2022 Author responded Author comments - Mohammed E. A. Hammouda
Resubmission - Version 4
8 Dec 2022 Submitted Manuscript version 4
10 Dec 2022 Reviewed Reviewer Report
11 Dec 2022 Reviewed Reviewer Report
17 Dec 2022 Reviewed Reviewer Report
23 Feb 2023 Author responded Author comments - Mohammed E. A. Hammouda
Resubmission - Version 5
23 Feb 2023 Submitted Manuscript version 5
24 Feb 2023 Author responded Author comments - Mohammed E. A. Hammouda
Resubmission - Version 6
24 Feb 2023 Submitted Manuscript version 6
1 Mar 2023 Author responded Author comments - Mohammed E. A. Hammouda
Resubmission - Version 7
1 Mar 2023 Submitted Manuscript version 7
Publishing
3 Mar 2023 Editorially accepted
14 Mar 2023 Article published 10.1186/s13065-023-00936-z

You can find further information about peer review here.

Back to article page